Emotion Regulation and Emotion Perception (EREP)

February 8, 2021 updated by: Duke University

Evaluating the Impact of an Emotion Regulation Intervention on Emotion Perception

The purpose of this study is to assess the impact of a brief, emotion regulation intervention on the ability to perceive other people's emotions.

Study Overview

Detailed Description

Decision to close enrollment was made on January 2, 2020.

Study Type

Interventional

Enrollment (Actual)

91

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. ages 18-55;
  2. have a smartphone and agree to receive text-messages;
  3. have difficulty with their relationships or social interactions;
  4. high emotion dysregulation, assessed with the Difficulties with Emotion Regulation Scale (DERS)(Gratz & Roemer, 2004) with scores over 90.

Exclusion Criteria:

  1. Current mania;
  2. Meets full criteria for any current psychotic disorder;
  3. Currently/chronically homeless;
  4. Current suicidal ideation;
  5. Psychiatric hospitalization within past 6 months;
  6. Unable to read, blind or deaf. Our previous study recruited only participants who were currently in treatment, but this study will include both participants who are currently in treatment, as well as those who are not in treatment.
  7. high self-reported autistic traits, as assessed by the Autism Spectrum Quotient (Auyeung & Baron-Cohen, 2012).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Mindful Breathing
Participants receive training in a mindful breathing skill to regulate their emotional distress during a stressor task. They will then receive one week of reminders to use this skill, delivered through their mobile phones.
Training in a mindful breathing skill that reduces emotional distress
ACTIVE_COMPARATOR: Habituation
Participants receive an exposure/habituation intervention to regulate their emotional distress during a stressor task. They will then receive one week of reminders, delivered through their mobile phones.
An exposure procedure that reduces emotional distress through habituation
PLACEBO_COMPARATOR: Control
Participants complete the stressor task with no emotion regulation training. Similar to the other conditions, they will then receive one week of reminders, delivered through their mobile phones to test for placebo effects.
No emotion regulation intervention, placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Ability to Perceive Negative and Positive Emotional Expressions, as Measured by a Behavioral Computer-based Assessment
Time Frame: During the laboratory experiment (week 1)
Emotion perception is measured by a computer-based behavioral assessment during the laboratory session. Scores for negative emotional expressions range from 0-100%, with higher scores indicating greater emotion perception accuracy.
During the laboratory experiment (week 1)
Changes in Emotion Perception, as Measured by a Phone-based Behavioral Assessment
Time Frame: After the one week of phone-based intervention
Perception of positive emotional expressions and negative emotional expressions are measured by a behavioral phone-based assessment, delivered multiple times over one week via mobile phones. Scores for ratings of emotional valence range from 0-9, with higher scores as more positive emotional valence and lower scores as more negative emotional valence.
After the one week of phone-based intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Emotional Distress, as Measured by Subjective Units of Distress (SUDS)
Time Frame: Beginning of Week one laboratory experiment, End of Week one laboratory experiment
SUDS are measured on a 10-point Likert self-report scale of Subjective Units of Distress, ranging from 0-9. Scores are changes in SUDS ratings from before hearing the tone to after the tone, with greater scores indicating greater reductions in distress (positive outcomes). SUDS score was evaluated at the beginning of the laboratory experiment, and then at the very end of the lab experiment. The change score was calculated by subtracting the beginning score from the end score.
Beginning of Week one laboratory experiment, End of Week one laboratory experiment

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Emotional Arousal, as Measured by Skin Conductance Response (SCR)
Time Frame: Laboratory assessment, up to one week
Changes in emotional arousal are measured physiologically with electrodermal activity. Skin conductance response measures phasic changes in electrical conductivity of skin, with a minimum threshold of 0.01μS with higher values indicating greater changes in emotional arousal.
Laboratory assessment, up to one week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 4, 2019

Primary Completion (ACTUAL)

December 2, 2019

Study Completion (ACTUAL)

December 2, 2019

Study Registration Dates

First Submitted

December 28, 2018

First Submitted That Met QC Criteria

December 28, 2018

First Posted (ACTUAL)

January 2, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 24, 2021

Last Update Submitted That Met QC Criteria

February 8, 2021

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00089935
  • 1F31MH117830-01A1 (NIH)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Will check with sponsors on Duke's policies for data sharing and may update the plan in the future.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emotions

Clinical Trials on Mindful Breathing

3
Subscribe